skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

33 Total results for product and free and sample content found

Biomedtracker: 開発中医薬品をFDA承認確率で評価

Biomedtracker Q3 2019 Outlook Report Extract

29 Jul 2019

In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.   

Topic drug-development-landscape drug-review research strategy

Meddevicetracker: 医療機器の市場調査分析・データベース

MeddeviceTracker Q3 2019 Outlook Report

24 Jul 2019

In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

Topic strategy research drug-development-landscape drug-review

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

New Science As A Business Growth Strategy

By Sanskriti Thakur and Gordon Murphy 04 Jul 2019

Finding innovative ways to adapt the biopharma business model to external and internal challenges is a key competitive differentiator for today’s C-suite leadership.

Topic BioPharmaceutical Research

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Daiichi Sankyo Realigns Japan R&D As Oncology Comes To Fore

02 Jul 2019

Daiichi Sankyo unveils further restructuring moves, this time mainly in its R&D functions in Japan, as part of an ongoing strategic pivot towards oncology.

Topic research

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Sanofi Google Alliance To Apply Big Data To R&D Commercial And Marketing Operations

By Joseph Haas 21 Jun 2019

Sanofi says the virtual innovation lab it will create with Google will enable precision health care and optimize R&D and commercial operations. Incoming CEO Hudson has been tasked with improving the pharma’s R&D and digital capabilities.

Topic research press-release

Medtrack: 製薬企業などヘルスケア企業情報のデータベース

Medtrack One Stop Shop Q&A Article Pack

11 Jun 2019

Our Ask-the-Analyst service is your direct hotline to the team of experts who cover all aspects of the Pharmaceutical market including R&D, clinical trials, market access, financing and licensing.

Topic clinical-trials research

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Building Bayer For The Next Decade And Navigating A Patent Cliff

10 Jun 2019

As Bayer prepares for several of its key products to lose patent exclusivity in four to five years’ time, In Vivo caught up with the company’s new head of pharma, Stefan Oelrich, to hear more on his strategy for the future – especially his plans for drug R&D, collaboration and a pipeline built on external innovation.

Topic drug-development-landscape research

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Pharma’s New R&D Models: Federating Innovation

By Melanie Senior 10 Jun 2019

Experiments are underway to solve pharma’s well-documented R&D productivity crisis. The industry is no longer focused only on buying new drugs via M&A, or on outsourcing discovery. Companies are also building new channels through which to access innovation, setting up different kinds of partnerships, and using new kinds of data. The shift involves re-thinking pharma’s place in healthcare.

Topic research drug-development-landscape

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。